# EDGAR Filing Document

**Accession Number:** 0001204876
**File Stem:** 0001213900-26-023169
**Filing Date:** 2026-3
**Character Count:** 12202
**Document Hash:** 292b9f3457c605ef1745bafa524a63e7
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-26-023169.hdr.sgml**: 20260303

**ACCESSION NUMBER**: 0001213900-26-023169

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20260220

**FILED AS OF DATE**: 20260303

**DATE AS OF CHANGE**: 20260303

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** BERRY DAVID A
- **CENTRAL INDEX KEY:** 0001204876

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-43135
- **FILM NUMBER:** 26716212

**MAIL ADDRESS:**
- **STREET 1:** C/O ELEVEN BIOTHERAPEUTICS, INC.
- **STREET 2:** 215 FIRST STREET, SUITE 400
- **CITY:** CAMBRIDGE
- **STATE:** MA
- **ZIP:** 02142
**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Handel Rose LLC
- **CENTRAL INDEX KEY:** 0002108994

**ORGANIZATION NAME:**
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-43135
- **FILM NUMBER:** 26716211

**BUSINESS ADDRESS:**
- **STREET 1:** 240 W 40TH STREET OFFICE 205
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10018
- **BUSINESS PHONE:** 339-234-9160

**MAIL ADDRESS:**
- **STREET 1:** 240 W 40TH STREET OFFICE 205
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10018
**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Berry Eric Z.
- **CENTRAL INDEX KEY:** 0002115065

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-43135
- **FILM NUMBER:** 26716210

**MAIL ADDRESS:**
- **STREET 1:** C/O AVERIN CAPITAL ACQUISITION CORP.
- **STREET 2:** 240 W 40TH STREET OFFICE 205
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10018
**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Averin Capital Acquisition Sponsor LLC
- **CENTRAL INDEX KEY:** 0002108995

**ORGANIZATION NAME:**
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-43135
- **FILM NUMBER:** 26716213

**BUSINESS ADDRESS:**
- **STREET 1:** 240 W 40TH STREET OFFICE 205
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10018
- **BUSINESS PHONE:** 339-234-9160

**MAIL ADDRESS:**
- **STREET 1:** 240 W 40TH STREET OFFICE 205
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10018
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Averin Capital Acquisition Corp.
- **CENTRAL INDEX KEY:** 0002096900
- **STANDARD INDUSTRIAL CLASSIFICATION:** BLANK CHECKS [6770]
- **ORGANIZATION NAME:** 05 Real Estate & Construction
- **EIN:** 981891461
- **STATE OF INCORPORATION:** E9
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 9 BARTLET ST. STE 137
- **CITY:** ANDOVER
- **STATE:** MA
- **ZIP:** 01810
- **BUSINESS PHONE:** 339-234-9160

**MAIL ADDRESS:**
- **STREET 1:** 9 BARTLET ST. STE 137
- **CITY:** ANDOVER
- **STATE:** MA
- **ZIP:** 01810

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Averin Capital Acquisition Sponsor LLC<br><sub>(Last) (First) (Middle)</sub><br>C/O AVERIN CAPITAL ACQUISITION CORP.<br>240 W 40TH STREET, OFFICE 205<br><sub>(Street)</sub><br>NEW YORK, NY 10018<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2026-02-20 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director [X] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_See Remarks_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>Averin Capital Acquisition Corp. [ ACAAU ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>BERRY DAVID A<br><sub>(Last) (First) (Middle)</sub><br>C/O AVERIN CAPITAL ACQUISITION CORP.<br>240 W 40TH STREET, OFFICE 205<br><sub>(Street)</sub><br>NEW YORK, NY 10018<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2026-02-20 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director [X] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_See Remarks_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>Averin Capital Acquisition Corp. [ ACAAU ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Handel Rose LLC<br><sub>(Last) (First) (Middle)</sub><br>C/O AVERIN CAPITAL ACQUISITION CORP.<br>240 W 40TH STREET, OFFICE 205<br><sub>(Street)</sub><br>NEW YORK, NY 10018<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2026-02-20 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [X] 10% Owner<br>[ ] Officer (give title below) [ ] Other (specify below)<br>_ _ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>Averin Capital Acquisition Corp. [ ACAAU ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Berry Eric Z.<br><sub>(Last) (First) (Middle)</sub><br>C/O AVERIN CAPITAL ACQUISITION CORP.<br>240 W 40TH STREET, OFFICE 205<br><sub>(Street)</sub><br>NEW YORK, NY 10018<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2026-02-20 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [X] 10% Owner<br>[ ] Officer (give title below) [ ] Other (specify below)<br>_ _ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>Averin Capital Acquisition Corp. [ ACAAU ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Class A Ordinary Shares | 2025-02-20 |  | P |  | 200000<sup>(1)</sup> | A | $10 | 200000<sup>(1)</sup> | D<sup>(2)</sup> |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |

---

### Footnotes:

(1) Represents shares underlying the private placement units (each unit consisting of one Class A ordinary share and one-sixth of one warrant, each whole warrant exercisable to purchase one Class A ordinary share) directly held by Averin Capital Acquisition Sponsor LLC (the "Sponsor"), and which were acquired pursuant to a Private Placement Units Purchase Agreement by and between the Sponsor and Averin Capital Acquisition Corp. (the "Issuer"). Does not include 7,187,500 Class B ordinary shares, which shares will automatically convert into Class A ordinary shares at the time of the Issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to adjustment as described under the heading "Description of Securities--Founder Shares" in the Issuer's registration statement on Form S-1 (File No. 333-293082).

(2) The Sponsor is the record holder of such shares. Handel Rose LLC, is the sole managing member of the Sponsor and controls the management of the Sponsor, including the exercise of voting and investment discretion over the securities of the Issuer held by the Sponsor. Eric Berry and David Berry are the managers of Handel Rose LLC. David Berry and Eric Berry both may be deemed to have beneficial ownership of the securities held of record by the Sponsor. Each such person disclaims any beneficial ownership of the securities reported herein other than to the extent of any pecuniary interest they may have therein, directly or indirectly.

**Remarks:**
Chief Executive Officer and Chairman of the Board of Directors.

This Form 4/A amends the Form 4 filed on February 20, 2026 (the "Original Form 4") solely to add Eric Berry as an additional Reporting Person. Although Eric Berry was identified in the Original Form 4, he was not separately listed as a Reporting Person at that time because he did not yet have EDGAR access codes.

**Signature:** /s/ Averin Capital Acquisition Sponsor LLC, By: Handel Rose LLC, its Managing Member, By: /s/ David Berry, Name: David Berry, Title: Manager  
**Date:** 2026-03-03

**Signature:** /s/ Handel Rose LLC, By: David Berry, Managing Member  
**Date:** 2026-03-03

**Signature:** /s/ David Berry  
**Date:** 2026-03-03

**Signature:** /s/ Eric Berry  
**Date:** 2026-03-03

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**